STAT+: Will the Treasury restrict U.S. investment in the Chinese biotech sector?

Biblical Context

The reported use of GLP-1 medications for addiction treatment connects most directly with biblical concerns about sobriety, self-control, responsible care, and honest treatment of vulnerable people. Ephesians 5:18 specifically warns against drunkenness and contrasts it with being filled by the Spirit; this supports taking alcohol misuse seriously, but it does not prescribe a particular medical treatment. First Peter 5:8 calls believers to be sober-minded and vigilant, a principle relevant to addiction care and to careful evaluation of treatment claims. The article also raises an ethical question about how emerging therapies are marketed. Scripture commends truthful conduct and concern for people who may be vulnerable, which is relevant when companies promote off-label prescriptions or compounded products whose regulatory status and evidence may differ from approved therapies. These passages do not establish that off-label prescribing is inherently wrong, nor do they determine whether the companies acted unlawfully. They support careful, truthful, and responsible treatment rather than a conclusion about the drugs themselves. No specific biblical prophecy is meaningfully identified in this development.